Latest filing published 06 Aug 2021 for Rossari Biotech Limited, €55k.
Filing timeline
BuySaleRupesh Ruparelia: trading record in brief
Rupesh Ruparelia, listed as chief executive, appears in our data through filings on Rossari Biotech Limited shares, published by SEBI (PIT + SAST). Between 17 July 2021 and 4 August 2021, the trades on record add up to 3 filings.
Not one of the filings records a straightforward purchase or sale on the market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The newest entry dates from 6 August 2021: a transaction of €55k, in Rossari Biotech Limited. Between a trade and the moment it shows up on SEBI (PIT + SAST), the median delay is 2 days. This delay matters because a trade only becomes useful information once it is public. These figures are compiled from regulatory filings published by SEBI (PIT + SAST). They describe what insiders did and are not a recommendation.
Companies and markets linked to Rupesh Ruparelia
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 3,500 shares@ ₹1,379.84290.0003% mcap32.1% of flowEquity SharesSEBI:c4059dd8ec8bad49ae7f5e7f946e5f30283757a6
- 4,000 shares@ ₹1,391.750.0003% mcap36.9% of flowEquity SharesSEBI:d165f9299c064e9868d770608b535096012891ac
- 4,000 shares@ ₹1,167.450.0003% mcap31.0% of flowEquity SharesSEBI:cca436a84491c58419c61c4f8a96fbc41e0845a8Canonical exit: 15 Oct 2021 (T+90)
3 of 3 declarations